Simple Summary The number of children and adults with cancer that are completely cured is
still increasing thanks to effective anti-cancer therapy, but they may be confronted with the …

Purpose This review provides an update on the current clinical, epidemiological and
pathophysiological evidence alongside the diagnostic, prevention and treatment approach …

Peripheral neuropathy is one of the most common side effects of chemotherapy, affecting up
to 60% of all cancer patients receiving chemotherapy. Moreover, paclitaxel induces …

Controlled drug delivery formulations have revolutionized treatments for a range of health
conditions. Over decades of innovation, layer-by-layer (LbL) self-assembly has emerged as …

This review provides an update on the current clinical and preclinical understanding of
chemotherapy induced peripheral neuropathy (CIPN). The overview of the clinical syndrome …

Peripheral neuropathies are characterized by nerves damage and axonal loss, and they
could be classified in hereditary or acquired forms. Acquired peripheral neuropathies are …

Background Despite the remarkable advances made in the diagnosis and treatment of
cancer during the past couple of decades, it remains the second largest cause of mortality in …

Cancer is the second leading cause of death in the world with around 9.6 million deaths in
2018, approximately 70% of which occurred in the middle-and low-income countries; …

Chemotherapy‐induced peripheral neurotoxicity (CIPN) is a potentially dose‐limiting side
effect of several commonly used cytotoxic chemotherapy agents. The main pharmacological …

Local anaesthetics, delivered percutaneously through a needle, have been used for over a
century to provide perioperative anaesthesia and analgesia. However, the duration of a …